Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 3:59 pm Sale |
2022-12-31 | 13G | Infinity Pharmaceuticals, Inc. INFIQ |
Polar Capital Holdings Plc | 2,071,242 2.300% |
-2,928,758 (-58.58%) |
Filing History |
| 2023-02-09 11:22 am Sale |
2022-12-30 | 13G | Infinity Pharmaceuticals, Inc. INFIQ |
The Vanguard Group | 5,313,679 5.950% |
-469,754 (-8.12%) |
Filing History |
| 2022-07-08 4:56 pm Sale |
2022-06-30 | 13G | Infinity Pharmaceuticals, Inc. INFIQ |
BLACKROCK INC BLK |
2,305,486 2.600% |
-4,362,017 (-65.42%) |
Filing History |
| 2022-02-14 2:01 pm Sale |
2021-12-31 | 13G | Infinity Pharmaceuticals, Inc. INFIQ |
BIOTECHNOLOGY VALUE FUND L P | 6,353,645 7.100% |
-2,030,000 (-24.21%) |
Filing History |
| 2022-02-14 1:38 pm Sale |
2021-12-31 | 13G | Infinity Pharmaceuticals, Inc. INFIQ |
EcoR1 Capital LLC | 0 0.000% |
-4,368,500 (Position Closed) |
Filing History |
| 2022-02-14 10:41 am Purchase |
2021-12-31 | 13G | Infinity Pharmaceuticals, Inc. INFIQ |
Polar Capital Holdings Plc | 5,000,000 5.600% |
5,000,000 (New Position) |
Filing History |
| 2022-02-10 08:17 am Purchase |
2021-12-31 | 13G | Infinity Pharmaceuticals, Inc. INFIQ |
The Vanguard Group | 5,783,433 6.500% |
3,888,514 (+205.21%) |
Filing History |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Infinity Pharmaceuticals, Inc. INFIQ |
BLACKROCK INC BLK |
6,667,503 7.500% |
5,754,043 (+629.92%) |
Filing History |
| 2022-01-18 4:12 pm Sale |
2021-12-31 | 13G | Infinity Pharmaceuticals, Inc. INFIQ |
Integrated Core Strategies (US) LLC | 743,271 0.800% |
-4,319,036 (-85.32%) |
Filing History |
| 2021-06-17 4:16 pm Purchase |
2021-06-10 | 13G | Infinity Pharmaceuticals, Inc. INFIQ |
Integrated Core Strategies (US) LLC | 5,062,307 5.700% |
5,062,307 (New Position) |
Filing History |
| 2021-02-19 5:10 pm Unchanged |
2021-02-17 | 13G | Infinity Pharmaceuticals, Inc. INFIQ |
BIOTECHNOLOGY VALUE FUND L P | 8,383,645 9.960% |
0 (Unchanged) |
Filing History |
| 2021-02-16 4:30 pm Sale |
2021-02-11 | 13D | Infinity Pharmaceuticals, Inc. INFIQ |
BIOTECHNOLOGY VALUE FUND L P | 8,383,645 13.100% |
-2,343,323 (-21.85%) |
Filing History |
| 2021-02-12 5:20 pm Purchase |
2020-12-31 | 13G | Infinity Pharmaceuticals, Inc. INFIQ |
Opaleye Management Inc. | 3,171,800 4.940% |
171,400 (+5.71%) |
Filing History |
| 2021-01-26 5:26 pm Sale |
2021-01-22 | 13D | Infinity Pharmaceuticals, Inc. INFIQ |
BIOTECHNOLOGY VALUE FUND L P | 10,726,968 16.700% |
-6,700,000 (-38.45%) |
Filing History |
| 2021-01-26 12:21 pm Purchase |
2021-01-22 | 13G | Infinity Pharmaceuticals, Inc. INFIQ |
EcoR1 Capital LLC | 4,368,500 6.800% |
4,368,500 (New Position) |
Filing History |
| 2020-11-12 5:13 pm Unchanged |
2020-11-09 | 13D | Infinity Pharmaceuticals, Inc. INFIQ |
BIOTECHNOLOGY VALUE FUND L P | 17,426,968 27.100% |
0 (Unchanged) |
Filing History |
| 2020-09-18 6:48 pm Purchase |
2020-09-09 | 13G | Infinity Pharmaceuticals, Inc. INFIQ |
Opaleye Management Inc. | 3,000,400 5.100% |
3,000,400 (New Position) |
Filing History |